BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 11344576)

  • 1. Increased formation of ursodeoxycholic acid in patients treated with chenodeoxycholic acid.
    Salen G; Tint GS; Eliav B; Deering N; Mosbach EH
    J Clin Invest; 1974 Feb; 53(2):612-21. PubMed ID: 11344576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 7-ketolithocholic acid on bile acid metabolism in humans.
    Salen G; Verga D; Batta AK; Tint GS; Shefer S
    Gastroenterology; 1982 Aug; 83(2):341-7. PubMed ID: 7084613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ursodeoxycholic acid, 7-ketolithocholic acid, and chenodeoxycholic acid are primary bile acids of the nutria (Myocastor coypus).
    Tint GS; Bullock J; Batta AK; Shefer S; Salen G
    Gastroenterology; 1986 Mar; 90(3):702-9. PubMed ID: 3943698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative formation of lithocholic acid from chenodeoxycholic and ursodeoxycholic acids in the colon.
    Bazzoli F; Fromm H; Sarva RP; Sembrat RF; Ceryak S
    Gastroenterology; 1982 Oct; 83(4):753-60. PubMed ID: 7106506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ursodeoxycholic acid, chenodeoxycholic acid, and 7-ketolithocholic acid are primary bile acids of the guinea pig.
    Tint GS; Xu GR; Batta AK; Shefer S; Niemann W; Salen G
    J Lipid Res; 1990 Jul; 31(7):1301-6. PubMed ID: 2401860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transformation of chenodeoxycholic acid and ursodeoxycholic acid by human intestinal bacteria.
    Fedorowski T; Salen G; Tint GS; Mosbach E
    Gastroenterology; 1979 Nov; 77(5):1068-73. PubMed ID: 488633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion of 7-ketolithocholic acid to ursodeoxycholic acid by human intestinal anaerobic microorganisms: interchangeability of chenodeoxycholic acid and ursodeoxycholic acid.
    Higashi S; Setoguchi T; Katsuki T
    Gastroenterol Jpn; 1979 Oct; 14(5):417-24. PubMed ID: 520764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrophilic 7 beta-hydroxy bile acids, lovastatin, and cholestyramine are ineffective in the treatment of cerebrotendinous xanthomatosis.
    Batta AK; Salen G; Tint GS
    Metabolism; 2004 May; 53(5):556-62. PubMed ID: 15131757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study.
    Thistle JL; Larusso NF; Hofmann AF; Turcotte J; Carlson GL; Ott BJ
    Dig Dis Sci; 1982 Feb; 27(2):161-8. PubMed ID: 7075411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of ursodeoxycholic acid from chenodeoxycholic acid in the human colon: studies of the role of 7-ketolithocholic acid as an intermediate.
    Fromm H; Sarva RP; Bazzoli F
    J Lipid Res; 1983 Jul; 24(7):841-53. PubMed ID: 6631218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile acids in bile during long-term chenodeoxycholic acid treatment.
    Bremmelgaard A; Pedersen L
    Scand J Gastroenterol; 1976; 11(2):161-5. PubMed ID: 1265436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass spectrometry identification of biliary bile acids in bile from patients with gallstones before and during treatment with chenodeoxycholic acid. An ancillary study of the National Cooperative Gallstone Study.
    Stellaard F; Klein PD; Hofmann AF; Lachin JM
    J Lab Clin Med; 1985 Apr; 105(4):504-13. PubMed ID: 3981060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis.
    Danzinger RC; Hofmann AF; Thistle JL; Schoenfield LJ
    J Clin Invest; 1973 Nov; 52(11):2809-21. PubMed ID: 4583981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transformation of chenodeoxycholic acid to ursodeoxycholic acid in patients with Crohn's disease.
    Miwa H; Yamamoto M; Nishida T; Yao T
    Gastroenterology; 1986 Mar; 90(3):718-23. PubMed ID: 3943699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF; Thistle JL
    Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
    Fromm H; Roat JW; Gonzalez V; Sarva RP; Farivar S
    Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absorption of 7-ketolithocholic acid in rat jejunum, ileum and colon.
    Walker S; Stiehl A; Raedsch R; Klöters P; Kommerell B
    Z Gastroenterol; 1985 Dec; 23(12):681-3. PubMed ID: 4090568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ursodeoxycholic acid administration on biliary lipid composition and bile acid kinetics in cholesterol gallstone patients.
    Roda E; Roda A; Sama C; Festi D; Mazzella G; Aldini R; Barbara L
    Dig Dis Sci; 1979 Feb; 24(2):123-8. PubMed ID: 428300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of serum determinations for prediction of increased ursodeoxycholic and chenodeoxycholic levels in bile.
    Bazzoli F; Fromm H; Roda A; Tunuguntla AK; Roda E; Barbara L; Amin P
    Dig Dis Sci; 1985 Jul; 30(7):650-4. PubMed ID: 4006647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Faecal bile acid loss and bile acid pool size during short-term treatment with ursodeoxycholic and chenodeoxycholic acid in patients with radiolucent gallstones.
    Salvioli G; Salati R
    Gut; 1979 Aug; 20(8):698-704. PubMed ID: 488763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.